AI assistant
NEOGENOMICS INC — Director's Dealing 2021
Mar 4, 2021
32227_dirs_2021-03-03_4065b140-d9a6-4149-9f62-0ac90c3f3a49.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-03-01
Reporting Person: McKenzie Kathryn B (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-01 | Common Stock | F | 169 | — | Disposed | 7760 | Direct |
| 2021-03-02 | Common Stock | F | 432 | — | Disposed | 7328 | Direct |
| 2021-03-02 | Common Stock | A | 6207 | — | Acquired | 13535 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-02 | Stock Option (Right to Buy) | $53.17 | A | 35171 | Acquired | 2028-03-02 | Common Stock (35171.0) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $9.07 | 2022-10-18 | Common Stock (25000.0) | 25000 | Direct |
| Stock Option (Right to Buy) | $8.03 | 2023-02-26 | Common Stock (40000.0) | 40000 | Direct |
| Stock Option (Right to Buy) | $19.6 | 2024-03-01 | Common Stock (13894.0) | 13894 | Direct |
| Stock Option (Right to Buy) | $28.33 | 2027-03-02 | Common Stock (37514.0) | 37514 | Direct |
Footnotes
F1: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock.
F2: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock.
F3: On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F4: On February 26, 2018, Ms. McKenzie was granted 48,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
F5: On March 1, 2019, Ms. McKenzie was granted 13,894 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F6: On March 2, 2020, Ms. McKenzie was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F7: On March 2, 2021, Ms. McKenzie was granted 35,171 stock options. These options vest ratably over the first four anniversary dates of the grant date.